Trxade Group

TRxADE HEALTH, Inc. provides an online platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focused on the United States pharmaceutical industry. The firm operates a web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. It also provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration and acts as a technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

Mobile Global Esports Inc

Virax Biolabs Group Ltd

High volume penny stocks for your September watch list. The post 3 High Volume Penny Stocks To Watch Before FOMC Meeting appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 High Volume Penny Stocks To Watch Before FOMC Meeting

TAMPA, FL / ACCESSWIRE / September 20, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare business subsidiary, has signed a Telemedicine Services Distribution Deal with Wakefern Food Corp., to deploy telemedicine services throughout ShopRite pharmacy-led locations in New Jersey, New York, Pennsylvania, Connecticut, and Maryland.

Wakefern Food Corp. and Bonum Health(TM), LLC (a TRxADE HEALTH Company) Ink a Telemedicine Services Deal

TAMPA, FL, Aug. 30, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare marketplace platform that connects buyers and sellers, today announced the launch of the Trxade Prime Plus program via its pharmaceutical wholesale business subsidiary, Integra Pharma Solutions LLC (d/b/a TRxADE Prime), to allow its member pharmacies better access to over 20,000 pharmaceutical products available for next day delivery without them incurring any additional shipping costs.

TRxADE HEALTH, Inc., Launches NEXT DAY Delivery Services Via TRxADE Prime Plus Program

LUTZ, FL / ACCESSWIRE / August 24, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that it has terminated the proposed underwritten public offering previously announced on August 23, 2022.

TRxADE HEALTH Announces Termination of Public Offering of Common Stock

LUTZ, FL / ACCESSWIRE / August 23, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced it has commenced an underwritten public offering.

TRxADE HEALTH Announces Proposed Public Offering of Common Stock

TAMPA, FL / ACCESSWIRE / August 16, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., announced today the appointment of Jeff Newell to the Company's advisory board.

TRxADE HEALTH, INC. Appoints Leading Pharmaceutical Industry Expert Mr.

TRxADE HEALTH, Inc. (NASDAQ:MEDS ) Q2 2022 Earnings Conference Call July 25, 2022 5:00 PM ET Company Participants Suren Ajjarapu - Founder, Chairman and CEO Janet Huffman - Chief Financial Officer Conference Call Participants Allen Klee - Maxim Group Howard Halpern - Taglich Brothers Operator Good afternoon, ladies and gentlemen. Thank you for standing by.

TRxADE HEALTH, Inc.'s (MEDS) CEO Suren Ajjarapu on Q2 2022 Results - Earnings Call Transcript

TRxADE (MEDS) delivered earnings and revenue surprises of -44.44% and 13.07%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

TRxADE (MEDS) Reports Q2 Loss, Tops Revenue Estimates

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL / ACCESSWIRE / July 25, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the 2022 second quarter (Q2) ended June 30, 2022.

TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results

TAMPA, FL / ACCESSWIRE / July 12, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare platform, today announced that Integra Pharma Solutions, LLC (d/b/a TRxADE Prime™)("Integra"), a wholly-owned pharmaceutical wholesale business, has secured a preferred distribution agreement with GALT Pharmaceuticals, LLC.

Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC

TAMPA, FL / ACCESSWIRE / July 11, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for second quarter 2022, after market close on July 25, 2022.

TRxADE HEALTH, INC. to Report Second Quarter 2022 Financial Results on Monday, July 25th at 5:00 p.m.

TAMPA, FL / ACCESSWIRE / May 19, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare business subsidiary, has launched Tele-Veterinary services for pets.

Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine Services

TRxADE HEALTH, Inc. (NASDAQ:MEDS ) Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Suren Ajjarapu – Founder, Chairman and Chief Executive Officer Janet Huffman – Chief Financial Officer Conference Call Participants Howard Halpern – Taglich Brothers Allen Klee – Maxim Group, LLC Operator Good afternoon, ladies and gentlemen. Thank you for standing by.

TRxADE HEALTH, Inc. (MEDS) CEO Suren Ajjarapu on Q1 2022 Results - Earnings Call Transcript

TRxADE (MEDS) delivered earnings and revenue surprises of -33.33% and 37.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

TRxADE (MEDS) Reports Q1 Loss, Tops Revenue Estimates

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL / ACCESSWIRE / May 9, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the 2022 first quarter (Q1) ended March 31, 2022.

TRxADE HEALTH Reports First Quarter Revenue Growth of 6% and Q1 2022 Financial Results

TRxADE (MEDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: TRxADE (MEDS) Q1 Earnings Expected to Decline

TAMPA, FL / ACCESSWIRE / April 25, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for first quarter 2022, after market close on May 9, 2022.

TRxADE HEALTH, INC. to Report First Quarter 2022 Financial Results on Monday, May 9th at 5:00 p.m.

TRxADE HEALTH, Inc. (MEDS) CEO Suren Ajjarapu on Q4 2021 Results - Earnings Call Transcript

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL / ACCESSWIRE / March 28, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE", "TRxADE HEALTH" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the fourth quarter (Q4) and year ended (FY) December 31, 2021.

TRxADE HEALTH Reports Year End 2021 Financial Results

TAMPA, FL / ACCESSWIRE / March 15, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS),is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., announced today that Company CEO Suren Ajjarapu has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, to be held March 28th - 30th from 9:00 a.m.

TRxADE HEALTH, INC. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m.

TAMPA, FL / ACCESSWIRE / March 14, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the fourth quarter and Year End 2021, after market close on March 28, 2022.

TRxADE HEALTH, INC. to Report Fourth Quarter and Year End 2021 Financial Results on Monday, March 28th at 5:00 p.m.

TAMPA, FL / ACCESSWIRE / February 23, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, healthcare platform and health service company, today announced that Bonum Health, a Digital Healthcare business subsidiary, has signed a Telemedicine Service Distribution agreement with Coborn's, Inc., a regional grocery chain with approximately (120+) Food and Pharmacy Grocery Stores across the Mid-West including: Minnesota, Michigan, Wisconsin, and North and South Dakota.

Coborn's, Inc. and Bonum Health(TM) (A TRxADE HEALTH Company) Ink Telemedicine Deal To Deploy Deeply Discounted Telemedicine to Uninsured and Under-Insured Consumers

TAMPA, FL / ACCESSWIRE / February 15, 2022 / TRxADE HEALTH, INC . (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the formation with Exchange Health, LLC, of a joint venture, SOSRx, LLC ("SOSRx"), a Pharmaceutical Platform.

TRxADE Health Forms Joint Venture SOSRx.com to Expand Medication Accessibility via Manufacturer Partnerships

TAMPA, FL / ACCESSWIRE / February 9, 2022 / TRxADE HEALTH, INC . (NASDAQ:MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that Suren Ajjarapu, the Chief Executive Officer of TRxADE, will present a company overview at the Aegis Capital Corp. Virtual Conference on February 24, 2022, at 1:30 PM Eastern.

TRxADE HEALTH to Present at Aegis Virtual Conference

TAMPA, FL / ACCESSWIRE / December 13, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that its Board of Directors has authorized the resumption of the previously disclosed stock repurchase program, which was modified by the Board of Directors to allow for the repurchase of up to a maximum of 100,000 shares of the Company's common stock, originally approved in May 2021, which was paused while the Company's ‘at-the-market' offering was ongoing, and which ‘at-the-market' offering was recently terminated.

News for Trxade Group Stock (MEDS)